002412.SZ Stock Analysis
00
Neutral
Based on Eyestock quantitative analysis, 002412.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Hunan Hansen Pharmaceutical Co. Ltd. engages in the research, development, manufacture, and sale of Chinese medicines. The company is headquartered in Yiyang, Hunan and currently employs 1,532 full-time employees. The company went IPO on 2010-05-25. The Company’s main products include Simotang oral liquid, used for abdominal distention and phlegmatic abdominalgia; Yushangling capsules, used for injuries from falls; Yinxingye capsules, used for stroke and chest distress, as well as Suoquan capsules, used for kidney deficiency, among others. The firm mainly distributes its products in domestic markets.